Delivery Order SPE2DB22D3102-SPE2DB25FL2EA
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $3,696.56, for Boostrix TDAP vaccine in 0.5mL syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 18, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,342.46 for Boostrix TDAP vaccine in 0.5mL syringe format on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price delivery order, valued at $2,807.39, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by July 31, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the nation's leading pharmaceutical distributor, for the supply of Boostrix TDAP vaccine in 0.5ml syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,318.30 with an ultimate completion date of September 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $140,147 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The order will be fulfilled at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal vaccine...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $133,843.21 on August 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...